According to the Complaint, the Company made false and misleading statements to the market. U.S. Centers for Medicare and Medicaid Services’ (“CMS”) rulemaking caused iRhythm’s business to suffer. The Company’s reimbursement rates plummeted as a result. Further uncertainty and weakness in the Company’s business was caused by a lack of national pricing in the CMS rule and fee schedule. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about iRhythm, investors suffered damages.
iRhythm Technologies, Inc.
Investors that purchased the Company’s securities and have suffered a loss, please fill in transaction information below, or email to firstname.lastname@example.org.
There is no cost or obligation associated with submitting your information. If you are a shareholder who suffered a loss, please submit your contact information and purchase information to participate in the putative class action.
We also encourage you to contact Lesley F. Portnoy of The Portnoy Law Firm, at 310.692.8883, to discuss your rights free of charge. You can also reach us through the firm’s website at www.portnoylaw.com, or by email at email@example.com.
If you choose to take no action, you can remain an absent class member.
Joining the case through the Portnoy Law website enables investors to learn about their legal claims and take an active role in recovering their losses.
The Portnoy Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
Portnoy Law Firm
Lesley F. Portnoy, Esq.,
1800 Century Park East, Suite 600
Los Angeles, CA 90067